Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs

DR Tompa, A Immanuel, S Srikanth… - International journal of …, 2021 - Elsevier
The infectious microscopic viruses invade living cells to reproduce themselves, and causes
chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to …

A review: Mechanism of action of antiviral drugs

S Kausar, F Said Khan… - International journal …, 2021 - journals.sagepub.com
Antiviral drugs are a class of medicines particularly used for the treatment of viral infections.
Drugs that combat viral infections are called antiviral drugs. Viruses are among the major …

[HTML][HTML] Fighting viruses with antibiotics: an overlooked path

P Colson, D Raoult - International journal of antimicrobial agents, 2016 - ncbi.nlm.nih.gov
Viruses are a serious threat for humans worldwide because there are in their ranks many
causative agents of potentially fatal infections and cancers [1, 2]. Despite this, emerging or re …

Current perspective of antiviral strategies against COVID-19

BA Ahidjo, MWC Loe, YL Ng, CK Mok… - ACS infectious …, 2020 - ACS Publications
COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020.
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …

Current strategies of antiviral drug discovery for COVID-19

M Mei, X Tan - Frontiers in Molecular Biosciences, 2021 - frontiersin.org
SARS-CoV-2 belongs to the family of enveloped, single-strand RNA viruses known as
Betacoronavirus in Coronaviridae, first reported late 2019 in China. It has since been …

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs

GEDA Abuo-Rahma, MFA Mohamed, TS Ibrahim… - RSC …, 2020 - pubs.rsc.org
The global outbreak of COVID-19 viral infection is associated with the absence of specific
drug (s) for fighting this viral infection. About 10 million people are already infected, about …

Emerging therapeutic approaches to combat COVID-19: present status and future perspectives

K Vivekanandhan, P Shanmugam… - Frontiers in Molecular …, 2021 - frontiersin.org
Coronavirus disease (COVID-19) has emerged as a fast-paced epidemic in late 2019 which
is disrupting life-saving immunization services. SARS-CoV-2 is a highly transmissible virus …

Antiviral therapies: advances and perspectives

BC Gonçalves, MG Lopes Barbosa… - Fundamental & …, 2021 - Wiley Online Library
Viral infections cause high morbidity and mortality, threaten public health, and impose a
socioeconomic burden. We have seen the recent emergence of SARS‐CoV‐2 (Severe …

A review of SARS-CoV-2 and the ongoing clinical trials

YF Tu, CS Chien, AA Yarmishyn, YY Lin… - International journal of …, 2020 - mdpi.com
The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) in
Wuhan, China, which rapidly grew into a global pandemic, marked the third introduction of a …

Bioactive natural antivirals: An updated review of the available plants and isolated molecules

S Mohan, MM Elhassan Taha, HA Makeen, HA Alhazmi… - Molecules, 2020 - mdpi.com
Viral infections and associated diseases are responsible for a substantial number of
mortality and public health problems around the world. Each year, infectious diseases kill …